Developing and testing new drugs costs a lot of money.
access to new drugs
Profit incentivizes innovation and helps fund research and development.
Review board’s new reference countries have more limited access to new and innovative drugs.
Under Medicare in the U.S., private insurers compete to offer coverage within regions.
The FDA is fundamentally reforming its drug approval process.